venBio Partners LLC

13F Filings History

Latest 13F report
Q3 2024 - Nov 14, 2024
Value $
$194M
Signature - Title
David Pezeshki - Chief Operating Officer
Location
San Francisco, CA
Summary
This page shows a list of all the recent 13F filings made by venBio Partners LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. venBio Partners LLC reported 6 stock holdings with total value $194M as of Q3 2024. Top holdings included PHVS, ALMS, HRMY, ARTV, and SLRN.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2024 6 $194M +$23.5M -$23.4M +$79K PHVS, ALMS, HRMY, ARTV, SLRN 13F-HR 11/14/2024, 04:20 PM
Q2 2024 6 $232M +$37.6M -$707K +$36.9M PHVS, ALXO, ALMS, HRMY, SLRN 13F-HR 8/14/2024, 04:12 PM
Q1 2024 5 $282M $0 -$337M -$337M ALXO, PHVS, HRMY, SLRN, ELEV 13F-HR 5/15/2024, 04:35 PM
Q4 2023 7 $667M +$18.4M -$26.4M -$7.99M RYZB, ALXO, PHVS, HRMY, SLRN 13F-HR 2/14/2024, 04:41 PM
Q3 2023 8 $353M +$126M -$48.4K +$126M RYZB, PHVS, ALXO, SLRN, HRMY 13F-HR 11/14/2023, 04:38 PM
Q2 2023 7 $276M +$112M -$61.5M +$50.8M SLRN, ALXO, PHVS, HRMY, VTYX 13F-HR 8/14/2023, 04:32 PM
Q1 2023 6 $180M $0 -$43.8M -$43.8M VTYX, ALXO, HRMY, PHVS, IMPLQ 13F-HR 5/15/2023, 04:44 PM
Q4 2022 7 $323M $0 -$94.3M -$94.3M VTYX, ALXO, HRMY, PHVS, IMPLQ 13F-HR 2/14/2023, 05:10 PM
Q3 2022 8 $432M $0 -$77.9M -$77.9M VTYX, ALXO, CINC, HRMY, AKRO 13F-HR 11/14/2022, 04:36 PM
Q2 2022 9 $351M +$3.1M -$17.5M -$14.4M ALXO, HRMY, VTYX, PHVS, CINC 13F-HR 8/15/2022, 04:59 PM
Q1 2022 10 $451M +$34.7M -$58.2M -$23.4M ALXO, HRMY, VTYX, PHVS, CINC 13F-HR 5/16/2022, 04:48 PM
Q4 2021 9 $555M +$99.5M -$24.9M +$74.7M ALXO, HRMY, VTYX, AKRO, PHVS 13F-HR 2/14/2022, 05:06 PM
Q3 2021 9 $1B $0 -$42.9M -$42.9M ALXO, HRMY, AKRO, PHVS, IMPLQ 13F-HR 11/15/2021, 04:23 PM
Q2 2021 10 $847M +$59.8M -$11M +$48.8M ALXO, HRMY, AKRO, PHVS, ELEV 13F-HR 8/16/2021, 04:43 PM
Q1 2021 8 $1.05B +$64.4M -$311K +$64.1M ALXO, HRMY, AKRO, PHVS, CMPI 13F-HR 5/17/2021, 04:22 PM
Q4 2020 7 $1.13B $0 -$8.63M -$8.63M ALXO, HRMY, AKRO, CMPI, APLS 13F-HR 2/16/2021, 04:46 PM
Q3 2020 8 $658M +$558M -$32.5M +$526M ALXO, HRMY, AKRO, CMPI, MTCR 13F-HR 11/16/2020, 04:26 PM
Q2 2020 4 $120M $0 -$21.2M -$21.2M AKRO, DTIL, APLS, VRNA 13F-HR 8/14/2020, 04:49 PM
Q1 2020 6 $117M $0 -$57.9M -$57.9M AKRO, DTIL, APLS, TPTX, MNLO 13F-HR 5/15/2020, 04:16 PM
Q4 2019 6 $233M $0 -$39.7M -$39.7M AKRO, DTIL, TPTX, APLS, MNLO Restatement 5/20/2020, 05:23 PM
Q3 2019 6 $211M $0 $0 AKRO, TPTX, DTIL, APLS, MNLO Restatement 5/20/2020, 05:22 PM
Q2 2019 6 $225M +$130M -$13.3M +$117M AKRO, DTIL, TPTX, APLS, MNLO Restatement 5/20/2020, 05:22 PM
Q1 2019 4 $123M +$76.6M -$5.15M +$71.4M DTIL, APLS, MNLO, VRNA Restatement 5/20/2020, 05:21 PM
Q4 2018 3 $38.1M $0 $0 APLS, VRNA, MNLO 13F-HR 5/26/2020, 03:56 PM